The 100 Most Influential CEOs in Oncology in 2025 (Full List)
"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing
TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC
Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera
Highlights from ASCO GI 2026 by Wafik El-Deiry
CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer
Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma
CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma
The ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026 is a virtual scientific webinar, scheduled for May 20, 2026, that focuses on the practical application of ESMO Clinical Practice Guidelines (CPG) in the management of metastatic breast cancer (MBC). Chaired by Evandro de Azambuja, the program features a real-world case presentation by Ana […]
The ASCO 2026 Annual Meeting is scheduled to take place from May 29 to June 2, 2026, at McCormick Place in Chicago. It is a major global oncology event organized by the American Society of Clinical Oncology, drawing over 40,000 oncology professionals worldwide. The meeting will feature a comprehensive five-day program with more than 200 […]
The Cell and Gene Therapy for Rare Diseases 2026 is a 5-day in-person workshop, scheduled for June 1-5, 2026, and is an intensive educational program focused on the development cycle of Advanced Therapy Medicinal Products (ATMPs). Hosted by EATRIS in collaboration with the European Rare Diseases Research Alliance (ERDERA), the course is specifically designed for […]
The Keystone Symposia conference, "Tumor Metabolism: New Frontiers in Diet, Microbiome and Beyond," is scheduled for June 8–11, 2026, and will be held at the INEC Killarney Convention Centre in Killarney, County Kerry, Ireland. This meeting is designed to broaden the scope of cancer metabolism research by moving beyond tumor-intrinsic metabolism to explore the reciprocal […]
The EACR 2026 Congress: Innovative Cancer Science is the Annual Congress of the European Association for Cancer Research (EACR). This four-day congress, dedicated to basic, preclinical, and translational cancer research, will take place from June 8-11, 2026, in Budapest, Hungary. The congress is designed to showcase the latest research, highlight a wide breadth of topics, […]
The 64th Annual Conference of the Particle Therapy Cooperative Group (PTCOG 64) is a specialized international scientific meeting focused on the clinical, physical, and biological aspects of particle therapy for cancer treatment. Scheduled for June 8–13, 2026, in Deauville, France, the conference includes an initial education program followed by a multi-day scientific program covering advancements […]
The EHA Congress 2026, set for June 11–14 in Stockholm, promises another outstanding scientific program that will bring together global leaders in hematology. Attendees can expect high-impact sessions, including the Opening Ceremony, Plenary Abstracts Session, and Presidential Sessions—all designed to foster deep scientific engagement and share groundbreaking research. In addition to the core plenary sessions, […]
The Advocates Webinar: Unlocking Next-Generation Therapies, hosted virtually by Friends of Cancer Research, is scheduled for Tuesday, June 11, 2026, from 1:00 PM to 2:00 PM ET. The webinar is designed to follow up on the public meeting held in May, focusing specifically on translating complex discussions around cell and gene therapy development into clear, […]
The ESMO Targeted Anticancer Therapies Asia Congress 2026 will be a three-day event dedicated to advancing cancer drug discovery and precision oncology in the Asia-Pacific region. Dates: June 12–14, 2026 Location: Kerry Hotel, Hong Kong SAR, China Abstract Submission Deadline: March 31, 2026 This congress serves as a key platform for researchers, industry leaders, and […]
The 26th Workshop on Methods in Clinical Cancer Research (MCCR workshop) is a prestigious professional development event for oncology researchers, taking place from June 13–18, 2026, in Sint Michielsgestel, Netherlands. Organized in collaboration by the European Organisation for Research and Treatment of Cancer (EORTC), the European Society for Medical Oncology (ESMO), and the American Association […]
The ELRIG Drug Discovery USA 2026, scheduled for June 16–17, 2026, is a free-to-attend event designed to bring together the global drug discovery community to discuss innovative research and emerging technologies. The forum provides a unique platform for scientists from academia and industry to network and collaborate within one of the world's leading biotech hubs. […]
The ESMO Gynaecological Cancers Congress 2026 will take place from 17–19 June in Copenhagen, Denmark, as well as online. This global event brings together experts, researchers, and healthcare professionals to explore the latest advancements in the diagnosis and treatment of ovarian, cervical, uterine, vaginal, and vulvar cancers. The programme features keynote lectures, interactive sessions, and […]
